Erkki Nissinen

Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study.

Piero Pollesello, Martti Ovaska, Juha Kaivola et al. · Journal of Biological Chemistry · 1994 · 233 citations · Full text

Levosimendan Binds, Molecular Pharmacology, Cardiac Muscle +14

Troponin C–Mediated Calcium Sensitization Induced by Levosimendan Does Not Impair Relaxation

Heimo Haikala, Erkki Nissinen, E Etemadzadeh et al. · Journal of Cardiovascular Pharmacology · 1995 · 226 citations

Cardiac Muscle, Muscle Function, Synaptic Transmission +17

Hypoxanthine‐guanine phosphoribosyltransferase variants: Correlation of clinical phenotype with enzyme activity

T Page, Bohdan Bakay, Erkki Nissinen et al. · Journal of Inherited Metabolic Disease · 1981 · 150 citations

Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone

Erkki Nissinen, Inge‐Britt Lindén, Eija Schultz et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1992 · 146 citations

Catechol-o-methyltransferase Inhibitor Entacapone, Biochemistry, Medicine +7

Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors

Reijo Bäckström, Erkki Honkanen, Aino Pippuri et al. · Journal of Medicinal Chemistry · 1989 · 144 citations · Full text